News Headlines

  1. Bio-Techne Announces Exosome Diagnostics Divestiture 8/5/2025

    Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement where Mdxhealth SA will acquire its Exosome Diagnostics Inc. business, including the ExoDx Prostate (EPI) test, CLIA-certified clinical laboratory and related assets.

  2. ScaleReady Announces A G-Rex® Grant Has Been Awarded To Sidra Medicine 8/5/2025

    ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Sidra Medicine, a women and children's hospital in Qatar, has been awarded a $100,000 G-Rex® Grant.

  3. Axplora Announces €6.5M Investment At Vizag Site And FDA Inspection Success Across Indian Operations 8/5/2025

    Axplora, a global leader in API small molecule manufacturing, today announced a significant investment at its Vizag site in India to expand production capacity and reinforce supply chain resilience.

  4. Bora Pharmaceuticals Announces Multi-Year Expansion For Midwest Manufacturing Site, As Upsher-Smith Entity Split Is Finalized 8/5/2025

    Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”) a global leader in pharmaceutical manufacturing, has announced plans for significant investments to expand its manufacturing and packaging capabilities at its facility in Maple Grove, Minnesota.

  5. Minaris Advanced Therapies Opens New State-Of-The-Art GMP Facility To Support Global Cell And Gene Therapy Growth 8/4/2025

    Minaris Advanced Therapies, a leading global contract development and manufacturing organization and testing provider, has announced the opening of its new GMP manufacturing facility in Munich, Germany.

  6. WuXi XDC Achieves GMP Release Of Newly Launched DP3 Facility At Wuxi Site, Scaling Further Drug Product Manufacturing Capacity 8/4/2025

    WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announced that the Drug Product 3 ("DP3") facility at the Wuxi site has completed GMP release at the end of July, signifying the company's relentless pursuit of excellence in capacity expansion and business growth.

  7. Alveolus Bio Secures Strategic Investment From Shilpa Medicare To Advance Groundbreaking Pulmonary Therapeutics 8/4/2025

    Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingham, AL, has announced a strategic financing round led by Shilpa Medicare Limited (BSE: 524742) (NSE: SHILPAMED), a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufacturing and biotechnology innovation.

  8. Atombeat And BioDuro Announce Strategic Partnership To Launch An AI-Powered Platform For Accelerated Peptide Drug Discovery 8/1/2025

    On July 30, 2025, Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), announced a strategic collaboration to an AI powered platform for accelerated peptide drug discovery.

  9. Mallinckrodt, Endo Complete Merger To Create Global, Scaled, Diversified Therapeutics Leader 8/1/2025

    Mallinckrodt plc and Endo, Inc. today announced that they have completed their merger to create a global, scaled, diversified therapeutics leader.

  10. Repligen Announces Strategic Partnership With Novasign To Further Advance Bioprocessing Digitalization 7/31/2025

    Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced Novasign and Repligen have entered into a strategic partnership to develop and integrate Novasign’s machine learning and modeling workflow into Repligen filtration systems.